FilingReader Intelligence
Fosun Pharma advances share repurchase, new drug application
March 6, 2025 at 05:05 PM UTC•By FilingReader AI
Shanghai Fosun Pharmaceutical Group (SSE:600196) has received a commitment letter from the Industrial and Commercial Bank of China for a special loan to support its A-share repurchase program. The loan will cover up to 90% of the repurchase amount, with a term of up to three years. The company plans to repurchase shares worth between 300 million and 600 million RMB.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
SSE:600196•Shanghai Stock Exchange
PharmaceuticalsShanghai Blue Chip
News Alerts
Get instant email alerts when Shanghai Fosun Pharmaceutical Group publishes news
Free account required • Unsubscribe anytime